Annual Cash & Cash Equivalents
$46.81 M
-$24.25 M-34.12%
December 31, 2023
Summary
- As of February 7, 2025, SCPH annual cash & cash equivalents is $46.81 million, with the most recent change of -$24.25 million (-34.12%) on December 31, 2023.
- During the last 3 years, SCPH annual cash & cash equivalents has fallen by -$25.00 million (-34.82%).
- SCPH annual cash & cash equivalents is now -60.43% below its all-time high of $118.30 million, reached on December 31, 2017.
Performance
SCPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$91.48 M
+$52.98 M+137.60%
September 30, 2024
Summary
- As of February 7, 2025, SCPH quarterly cash and cash equivalents is $91.48 million, with the most recent change of +$52.98 million (+137.60%) on September 30, 2024.
- Over the past year, SCPH quarterly cash and cash equivalents has increased by +$44.67 million (+95.42%).
- SCPH quarterly cash and cash equivalents is now -22.67% below its all-time high of $118.30 million, reached on December 31, 2017.
Performance
SCPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SCPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.1% | +95.4% |
| 3 y3 years | -34.8% | +28.7% |
| 5 y5 years | -47.7% | +28.7% |
SCPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.0% | at low | at high | +161.1% |
| 5 y | 5-year | -37.0% | at low | at high | +161.1% |
| alltime | all time | -60.4% | +2876.1% | -22.7% | +191.0% |
ScPharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $91.48 M(+137.6%) |
| Jun 2024 | - | $38.50 M(-34.1%) |
| Mar 2024 | - | $58.45 M(+24.8%) |
| Dec 2023 | $46.81 M(-34.1%) | $46.81 M(+33.6%) |
| Sep 2023 | - | $35.04 M(-50.9%) |
| Jun 2023 | - | $71.35 M(-5.4%) |
| Mar 2023 | - | $75.45 M(+6.2%) |
| Dec 2022 | $71.06 M(-4.3%) | $71.06 M(+72.1%) |
| Sep 2022 | - | $41.29 M(+0.3%) |
| Jun 2022 | - | $41.18 M(-20.2%) |
| Mar 2022 | - | $51.63 M(-30.5%) |
| Dec 2021 | $74.27 M(+3.4%) | $74.27 M(-6.4%) |
| Sep 2021 | - | $79.32 M(+5.8%) |
| Jun 2021 | - | $74.97 M(-1.1%) |
| Mar 2021 | - | $75.84 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $71.82 M(-1.1%) | $71.82 M(+62.2%) |
| Sep 2020 | - | $44.28 M(-43.9%) |
| Jun 2020 | - | $78.86 M(+4.7%) |
| Mar 2020 | - | $75.34 M(+3.7%) |
| Dec 2019 | $72.62 M(-18.8%) | $72.62 M(-13.1%) |
| Sep 2019 | - | $83.56 M(+5.2%) |
| Jun 2019 | - | $79.47 M(-4.7%) |
| Mar 2019 | - | $83.38 M(-6.8%) |
| Dec 2018 | $89.48 M(-24.4%) | $89.48 M(-6.1%) |
| Sep 2018 | - | $95.30 M(-5.4%) |
| Jun 2018 | - | $100.77 M(-7.8%) |
| Mar 2018 | - | $109.28 M(-7.6%) |
| Dec 2017 | $118.30 M(+201.2%) | $118.30 M(+276.3%) |
| Sep 2017 | - | $31.43 M(-20.0%) |
| Dec 2016 | $39.28 M(+2397.3%) | $39.28 M |
| Dec 2015 | $1.57 M | - |
FAQ
- What is scPharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for scPharmaceuticals?
- What is scPharmaceuticals annual cash & cash equivalents year-on-year change?
- What is scPharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for scPharmaceuticals?
- What is scPharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is scPharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of SCPH is $46.81 M
What is the all time high annual cash & cash equivalents for scPharmaceuticals?
scPharmaceuticals all-time high annual cash & cash equivalents is $118.30 M
What is scPharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, SCPH annual cash & cash equivalents has changed by -$24.25 M (-34.12%)
What is scPharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SCPH is $91.48 M
What is the all time high quarterly cash and cash equivalents for scPharmaceuticals?
scPharmaceuticals all-time high quarterly cash and cash equivalents is $118.30 M
What is scPharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, SCPH quarterly cash and cash equivalents has changed by +$44.67 M (+95.42%)